During the past decade, Studienzentrum Wilhelmshöhe GmbH conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 4 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 4 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Studienzentrum Wilhelmshöhe GmbH" are "Insomnia Disorder" (2 trials), "Narcolepsy" (1 trials) and "Obstructive Sleep Apnea" (1 trials). Many other conditions were trialed in "Studienzentrum Wilhelmshöhe GmbH" in a lesser frequency.

Most popular intervention types in "Studienzentrum Wilhelmshöhe GmbH" are "Drug" (4 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Daridorexant 25 mg" (2 trials), "Daridorexant 50 mg" (2 trials), "JZP-110" (2 trials), "Placebo" (2 trials) and "Placebo oral tablet" (2 trials). Other intervention names were less common.

The vast majority of trials in "Studienzentrum Wilhelmshöhe GmbH" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Studienzentrum Wilhelmshöhe GmbH". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in Studienzentrum Wilhelmshöhe GmbH, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Studienzentrum Wilhelmshöhe GmbH, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".